AstraZeneca PLC Cash Flow Reinvestment Rate
AstraZeneca PLC cash flow reinvestment rate. AstraZeneca PLC (ZEGA) has a Cash Flow Reinvestment Rate of 0.73x as of September 2025, reinvesting €3.73 Billion (capex €1.73 Billion plus investments €-2.00 Billion) from operating cash flow of €5.13 Billion. Explore AstraZeneca PLC cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of AstraZeneca PLC (2014–2024)
Cash flow reinvestment rate of AstraZeneca PLC from 2014 to 2024. Historical reinvestment intensity for AstraZeneca PLC across 11 annual periods. Explore AstraZeneca PLC (ZEGA) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
AstraZeneca PLC Cash Flow Reinvestment Rate by Year (2014–2024)
AstraZeneca PLC cash flow reinvestment rate by year from 2014 to 2024. Year-by-year capital reinvestment analysis for AstraZeneca PLC. For the full cash flow conversion analysis, see AstraZeneca PLC cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.06x | €12.57 Billion | €11.86 Billion | €4.59 Billion | ▲ +65.8% |
| 2023 | 0.64x | €6.62 Billion | €10.36 Billion | €3.39 Billion | ▲ +407.9% |
| 2022 | 0.13x | €1.23 Billion | €9.81 Billion | €1.09 Billion | ▼ -55.8% |
| 2021 | 0.28x | €1.70 Billion | €5.96 Billion | €1.09 Billion | ▼ -53.9% |
| 2020 | 0.62x | €2.96 Billion | €4.80 Billion | €961.00 Million | ▲ +65.9% |
| 2019 | 0.37x | €1.10 Billion | €2.97 Billion | €979.00 Million | ▼ -17.7% |
| 2018 | 0.45x | €1.18 Billion | €2.62 Billion | €1.04 Billion | ▼ -8.8% |
| 2017 | 0.50x | €1.77 Billion | €3.58 Billion | €1.33 Billion | ▼ -67.3% |
| 2016 | 1.52x | €6.28 Billion | €4.14 Billion | €2.31 Billion | ▲ +214.5% |
| 2015 | 0.48x | €1.60 Billion | €3.32 Billion | €1.33 Billion | ▲ +204.0% |
| 2014 | 0.16x | €1.12 Billion | €7.06 Billion | €1.01 Billion | — |